1
EXHIBIT 10.24
NOTE: CERTAIN PORTIONS OF THE EXHIBIT
HAVE BEEN OMITTED BASED UPON A
REQUEST FOR CONFIDENTIAL TREATMENT.
THE OMITTED PORTIONS HAVE BEEN
SEPARATELY FILED WITH THE COMMISSION.
LICENSE AGREEMENT
between
IOMED, INC.
and
UNIVERSITY OF UTAH RESEARCH FOUNDATION
2
TABLE OF CONTENTS
Article No..................................................... Page
1. DEFINITIONS.............................................. 2
2. GRANT.................................................... 3
3. ROYALTIES................................................ 4
4. CONFIDENTIALITY.......................................... 4
5. BOOKS AND RECORDS........................................ 5
6. LIFE OF THE AGREEMENT.................................... 5
7. TERMINATION BY LICENSOR.................................. 6
8. DISPOSITION OF PRODUCTS ON HAND UPON TERMINATION......... 6
9. PATENT PROSECUTION AND MAINTENANCE....................... 7
10. WARRANTY BY LICENSOR..................................... 8
11. AFFIRMATIONS BY LICENSOR................................. 9
12. PRIOR AGREEMENTS......................................... 10
13. INFRINGEMENT............................................. 10
14. WAIVER................................................... 11
15. ASSIGNABILITY............................................ 12
16. INDEMNITY................................................ 12
17. LATE PAYMENTS............................................ 12
18. NOTICES.................................................. 12
19. FOREIGN LAWS............................................. 13
20. GOVERNING LAWS........................................... 14
21. MISCELLANEOUS............................................ 14
i
3
LICENSE AGREEMENT
This LICENSE AGREEMENT is made and is effective as of October 1, 1992 (the
"Effective-,,Date") by and between the UNIVERSITY OF UTAH RESEARCH FOUNDATION,
having a principal place of business at ▇▇▇ ▇▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇ ▇▇▇▇
▇▇▇▇, ▇▇, ▇▇▇▇▇, hereinafter referred to as "LICENSOR", and IOMED, INC., having
a principal place of business at ▇▇▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇ ▇, ▇▇▇▇ ▇▇▇▇ ▇▇▇▇,
▇▇ ▇▇▇▇▇, hereinafter referred to as "LICENSEE".
W I T N E S S E T H:
WHEREAS, certain inventions, as listed in Exhibit "All and hereinafter
collectively referred to as "the Inventions", were made in the course of
research at the University of Utah by **** and are covered by LICENSORIS PATENT
RIGHTS as defined below;
WHEREAS, LICENSOR is desirous that the Inventions be developed and
utilized to the fullest extent so that the benefits can be enjoyed by the
general public; and
WHEREAS, LICENSOR and LICENSEE (hereinafter "the Parties") are party to
several agreements covering the Inventions dated ****, and the Parties wish to
terminate those agreements and to replace them with an agreement which better
suits the needs of their relationship;
NOW THEREFORE, for and in consideration of the covenants, conditions and
undertakings hereinafter set forth, it is agreed by and between the parties, as
follows:
1. DEFINITIONS
1.1 "LICENSORIS PATENT RIGHTS", as used herein, means patent rights to any
subject matter contained in the invention disclosures listed in Exhibit A and
claimed in or covered by the pending or issued U.S. and/or foreign patents and
applications recited in Exhibit "Bl' assigned to LICENSOR; any continuing or
divisional applications thereof assigned to LICENSOR; and any patents issuing on
said applications, continuing or divisional applications including reissues
assigned to LICENSOR.
1.2 "PRODUCTS" as used herein shall mean power supply units and electrode
kits for iontophoretic drug delivery; Utah Artificial Arms and ProControls where
such products are manufactured by or where such products are manufactured for
LICENSEE to LICENSEE'S design and specifications, whether Covered By LICENSOR'S
PATENT RIGHTS or not.
1.3 "...Covered By...", as used herein, means PRODUCTS that when made,
used, or sold would constitute, but for the license granted to LICENSEE pursuant
to this Agreement, an infringement of any claim or claims of LICENSOR'S PATENT
RIGHTS.
1
4
1.4 "NET SALES", as used herein, means sales revenue received by LICENSEE
for "PRODUCTS" sold by LICENSEE ****.
2. GRANT
2.1 LICENSOR hereby grants to LICENSEE an exclusive license under
LICENSORS PATENT RIGHTS to make, have made, use, and sell PRODUCTS throughout
the world where LICENSOR may lawfully grant such a license.
2.2 LICENSEE shall have full and exclusive right to all LICENSOR'S PATENT
RIGHTS with right to sell, sublicense or crosslicense under any terms to any
party with no consideration due to LICENSOR except as specifically set forth in
Paragraphs 3.1 and 3.2.
2.3 LICENSEE agrees to provide LICENSOR with copies of all such
sublicenses or cross-licenses, and LICENSOR agrees to keep such copies
confidential per Paragraph 4.
2.4 Pursuant to Paragraph 2.2, LICENSOR further agrees that LICENSEE may
specifically enter into a royalty-free cross-licensing agreement covering any or
all of the LICENSOR'S PATENT RIGHTS with ****.
2.5 Should this Agreement terminate for whatever reason, LICENSOR agrees
to negotiate in good faith with any sublicensee or cross-licensee per Paragraph
2.2 or 2.3 in order for a continuation of its rights on terms and conditions
similar to those granted LICENSEE.
2.6 LICENSOR reserves the right to use the Inventions for educational and
research purposes at the University of Utah.
3. ROYALTIES
3.1 As consideration for this license, LICENSEE shall pay to LICENSOR an
earned royalty of **** of NET SALES for the life of this Agreement. All monies
due to LICENSOR shall be payable in United States funds. Royalties accruing to
LICENSOR shall be paid to LICENSOR within forty-five (45) Days following the
calendar quarter in which NET SALES are made.
3.2 If within Forty-five (45) Days of the end of each fiscal year (ending
June 30th), LICENSEE has not paid to LICENSOR an amount equal to at least a
minimum annual royalty of ****, LICENSEE shall pay LICENSOR the difference. All
such payments in partial years will be on a pro rata basis.
4. CONFIDENTIALITY
4.1 LICENSEE acknowledges that LICENSOR is subject to the Utah
Governmental Records Access and Management Act (GRAMA) and that pursuant to
GRAMA, confidential information of LICENSEE disclosed to LICENSOR must be in
written or other tangible form
2
5
and appropriately marked as proprietary. In addition a claim stating the reasons
supporting such business confidentiality must also accompany the confidential
information (Utah Code Annotated 63-2-308). LICENSOR agrees to keep such
confidential information confidential to the extent allowable under the
applicable law.
5. BOOKS AND RECORDS
5.1 LICENSEE shall keep books and records accurately showing all PRODUCTS
manufactured, used, or sold under the terms of this Agreement. Such books and
records shall be open to inspection by representatives or agents of LICENSOR at
reasonable times and after reasonable advance notice, for the purpose of
verifying the accuracy of the quarterly reports and the royalties due or paid.
5.2 The fees and expenses of the representatives performing such an
examination shall be borne by LICENSOR.
5.3 These books and records required herein shall be preserved for at
least Five (5) Years from the date of the royalty payment to which they pertain.
6. LIFE OF THE AGREEMENT
6.1 This Agreement shall be in full force and effect from the Effective
Date and shall remain in effect until September 30, 2007; unless otherwise
terminated by operation of law or by acts of the parties in accordance with the
terms of this Agreement. After September 30, 2007, LICENSEE shall have a fully
paid-up license to practice LICENSOR'S PATENT RIGHTS pursuant to Article 2
without any further consideration to LICENSOR.
7. TERMINATION BY LICENSOR
7.1 It is expressly agreed that if LICENSEE should fail to make any
payment at the time that the same should be due or if LICENSEE should violate or
fail to perform any material covenant, condition, or undertaking- of this
Agreement on its part to be performed hereunder, then and in such event LICENSOR
may give written notice of such default to LICENSEE. If LICENSEE should fail to
repair such default within Sixty (60) Days of such notice or, in the
alternative, to request Arbitration in accordance with the rules of the American
Arbitration Association, LICENSOR shall have the right to terminate this
Agreement and the license granted herein-by written notice to LICENSEE. Upon
such notice of termination, this Agreement shall automatically terminate. Such
termination shall not relieve LICENSEE of its obligation to pay any royalty due
or owing at the time of such termination and shall not impair any accrued right
of LICENSOR. LICENSEE shall pay all attorney's fees and costs incurred by
LICENSOR in enforcing any obligation of LICENSEE or accrued right of LICENSOR
after termination.
8. DISPOSITION OF PRODUCTS ON HAND UPON TERMINATION
8.1 Upon termination of this Agreement by LICENSOR., LICENSEE shall
provide LICENSOR with a written inventory of all PRODUCTS in process of
manufacture, in use or in
3
6
stock and shall have the privilege of disposing of such PRODUCTS, but not more,
within a period of Ninety (90) Days, provided, however, that LICENSEE shall pay
royalties thereon and shall render reports thereon in the manner herein
provided.
9. PATENT PROSECUTION AND MAINTENANCE
9.1 LICENSEE shall diligently prosecute and maintain LICENSOR'S PATENT
RIGHTS using counsel of its choice and after due consultation with LICENSOR.
LICENSEE shall provide LICENSOR with copies of all relevant documentation so
that LICENSOR may be informed and apprised of the continuing prosecution, and
LICENSOR agrees to keep this documentation confidential to the extent allowable
under the law.
9.2 Pursuant to Paragraph 9.1 above LICENSEE shall be able .to exercise
sole and reasonable judgment in its decisions regarding the prosecution and
maintenance of LICENSOR'S PATENT RIGHTS. Should LICENSEE decide to abandon the
prosecution, maintenance or reinstatement of LICENSOR'S PATENT RIGHTS, it shall
notify LICENSOR of such decision within Forty Five (45) Days of any applicable
deadline. LICENSOR shall then have the opportunity to take over such
prosecution, maintenance or reinstatement at its own expense. LICENSEE shall
have no further rights in any patents on which LICENSOR takes over the
prosecution, maintenance or reinstatement unless LICENSEE requests such rights
and reimburses LICENSOR for costs incurred.
9.3 Subject to Paragraphs 9.1 and 9.2, LICENSEE agrees to pay all costs and
legal fees incurred for the prosecution, maintenance, defense, reinstatement and
taxes for such patents. LICENSOR agrees to reimburse LICENSEE for **** of such
reasonable costs in excess of **** per year. Such reimbursements shall not
exceed **** in any one year. Such reimbursements may be offset against earned
royalty payments due LICENSOR, ****. Such reimbursement shall be on a pro rata
basis for any partial year this Agreement is in effect.
10. WARRANTY BY LICENSOR
10.1 LICENSOR warrants that it has the lawful right to grant this
license.
10.2 LICENSOR makes no express or implied warranties of merchantability or
fitness of the Inventions for a particular purpose.
10.3 Nothing in this Agreement shall be construed as:
(a) a warranty or representation by LICENSOR as to the validity
or scope of any LICENSOR'S PATENT RIGHTS; or
4
7
(b) a warranty or representation that anything made, used, sold or
otherwise disposed of under any license granted in this Agreement is or
will be free from infringement of patents of third parties; or
(c) an obligation to bring or prosecute actions or suits
against third parties for patent infringement except as provided
herein; or
(d) conferring by implication, estoppel or otherwise any license or
rights under any patents of LICENSOR other than LICENSOR'S PATENT RIGHTS
as defined herein.
11. AFFIRMATIONS BY LICENSOR
11.1 LICENSOR affirms that to the best of its knowledge, other than what
has already been disclosed to LICENSEE per Exhibit "D", no invention disclosures
have been made to LICENSOR or the University of Utah Technology Transfer Office,
patents or patent applications pending relating to the PRODUCTS to which
LICENSEE may have certain rights under the agreements dated ****.
11.2 If LICENSOR becomes aware of any new invention disclosures with
creation dates prior to the Effective Date of this Agreement which LICENSEE may
have had rights to under the agreements referred to in Paragraph 11.1, LICENSOR
shall inform LICENSEE of such inventions. LICENSEE shall have Forty Five (45)
days to inform LICENSOR that it wants to include the rights to such inventions
in this Agreement.
11.3 Provided that this Agreement is currently in effect and remains in
effect for Fifteen (15) Years ending September 30, 2007, LICENSOR affirms the
assignment of any patents listed in Exhibit B.
12. PRIOR AGREEMENTS
12.1 The Parties agree to the following:
(a) The Artificial Arm Agreement dated July 29, 1976, the
Hemodialysis Agreement dated October 5, 1977 and the SPAD Agreement
dated August 27, 1980 are terminated in their entirety. All rights to
patents listed in Exhibit "C" will revert to LICENSOR;
(b) This Agreement embodies the entire understanding of the parties
and shall supersede all previous communications, representations or
understandings either oral or written between the parties relating to the
subject matter hereof.
13. INFRINGEMENT
13.1 In the event that LICENSEE or LICENSOR learn of infringement of any
of LICENSOR'S PATENT RIGHTS licensed under this Agreement, they shall call such
infringement to the attention of the other party thereto in writing and shall
provide the other party
5
8
with evidence of such infringement. LICENSOR and LICENSEE shall cooperate and
shall then attempt to terminate such infringement. In the event the Parties fail
to ▇▇▇▇▇ the infringing activity within Ninety (90) Days, LICENSEE or LICENSOR
may bring suit for patent infringement, naming the other as nominal party
plaintiff.
13.2 Any legal action as is brought shall be at the expense of the party
by whom suit is filed, hereinafter referred to as the Litigating Party. Any
damages or costs recovered by the Litigating Party in connection with such
infringement, after first reimbursing it for its costs and expenses of the
lawsuit, shall be equally divided between LICENSEE and LICENSOR except where
LICENSEE is the Litigating Party. In that case LICENSOR shall receive a royalty
per this Agreement from such damages and costs recovered with LICENSEE retaining
the remainder.
13.3 LICENSEE and LICENSOR agree to cooperate with the other in litigation
proceedings instituted hereunder but at the expense of the Litigating Party.
Such litigation shall be controlled by the Litigating Party. LICENSOR or
LICENSEE at their own expense, may be represented by counsel of their choice
pursuant to any suit brought by the Litigating Party.
14. WAIVER
14.1 It is agreed that no waiver by either party hereto of any breach or
default of any of the covenants or agreements herein set forth shall be deemed a
waiver as to any subsequent and/or similar breach or default.
15. ASSIGNABILITY
15.1 This Agreement is binding upon and shall inure to the benefit of
LICENSOR, its successors and assigns, but shall be personal to LICENSEE and
assignable by LICENSEE only with the written consent of LICENSOR; provided,
however, that LICENSEE, without consent, may assign or sell the same in
connection with the transfer or sale of all or substantially all of its business
relating- to its interest in LICENSOR'S PATENT RIGHTS as defined herein or in
the event of merger or consolidation with another company.
16. INDEMNITY
16.1 LICENSEE agrees to indemnify, hold harmless and defend LICENSOR, its
officers, employees, and agents, against any and all claims, suits, losses,
damage, costs, fees and expenses resulting from or arising out of exercise of
this license.
17. LATE PAYMENTS
17.1 In the event royalty payments or fees are not -received by LICENSOR
when due, LICENSEE shall pay to LICENSOR interest charges at the rate of ****
on the total royalties or fees due for the reporting period.
18. NOTICES
6
9
18.1 Any payment, notice or other communication required or permitted to
be given to either party hereto shall be deemed tohave been properly given and
to be effective: (a) on the date of delivery if delivered in person; or (b) on
the date of delivery if delivered by courier, express mail service or
first-class certified mail. Such notice shall be sent or delivered to the
respective address given below, or to such other address as it shall designate
by written notice given to the other party as follows:
In the case of LICENSEE:
IOMED, INC.
Attention: President
▇▇▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇ ▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇ ▇▇▇▇▇
In the case of LICENSOR:
UNIVERSITY OF UTAH
TECHNOLOGY TRANSFER ▇▇▇▇▇▇
▇▇▇ ▇▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇ ▇▇▇
▇▇▇▇ ▇▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇
19. FOREIGN LAWS
19.1 LICENSEE agrees to register this Agreement when required by
local/national law, to pay all costs and legal fees connected therewith, and to
otherwise insure that the local/ national laws affecting this Agreement are
fully satisfied. 19.2 LICENSEE further agrees to insure compliance with all
appropriate U.S. laws dealing with the export of technology or technical
information.
20. GOVERNING LAWS
20.1 This Agreement shall be interpreted and construed in accordance with
the laws of the State of Utah.
21. MISCELLANEOUS
21.1 The headings of the several sections are inserted for Convenience of
reference only and are not intended to be a part of or to affect the meaning or
interpretation of this Agreement.
21.2 This Agreement will not be binding upon the parties until it has been
signed hereinbelow by or on behalf of each party, in which event, it shall be
effective as of the date first above written.
21.3 No amendment or modification hereof shall be valid or binding upon
the parties unless made in writing and signed as aforesaid.
7
10
21.4 In case any one or more of the provisions contained in this Agreement
shall for any reason be held to be invalid, illegal or unenforceable in any
respect, such invalidity, illegality or unenforceability shall not affect any
other provisions hereof, but this Agreement shall be construed as if such
invalid or illegal or unenforceable provisions had never been contained herein.
IN WITNESS WHEREOF, both LICENSOR and LICENSEE have executed this
Agreement, in duplicate originals, by their respective officers hereunto duly
authorized, on the day and year hereinafter written.
8
11
Page (1) of (1)
EXHIBIT "A"
To License Agreement between
University of Utah Research Foundation
and Iomed, Inc.
Inventions
(by University of Utah designation numbers and titles)
U-0671 EPIDERMAL IONTOPHORESIS DEVICE
▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇ ▇▇▇▇▇, R. ▇▇▇▇ ▇▇▇▇▇▇▇ and
▇▇▇▇▇ ▇. ▇▇▇▇▇▇
U-1110 METHODS & APPARATUS FOR IONTOPHORESIS APPLICATION OF
MEDICAMENTS AT A CONTROLLED pH CIP
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ and ▇▇▇▇
▇▇▇▇▇▇
U-1209 ARTICULATED PROSTHETIC WRIST
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇
U-1231 ELECTRICALLY DRIVEN ARTIFICIAL ARM
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇, R. ▇▇▇▇ ▇▇▇▇▇▇▇ and ▇▇▇▇▇ ▇. ▇▇▇▇▇▇
U-1246 FLUID SELF-SEALING BIOELECTRODE
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇, ▇▇▇▇▇▇▇ ▇.
▇▇▇▇▇▇▇, ▇▇▇▇▇ ▇. ▇▇▇▇▇▇ and ▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇
12
EXHIBIT "B"
To License Agreement between
University of Utah Research Foundation
and Iomed, Inc.
[Pg 1 of 3]
IOMED PATENTS, TRADEMARKS AND APPLICATIONS
-----------------------------------------------------------------------------------------------------------------------------------
IOMED # WNJ NO. HHD NO. TITLE INVENTORS FILED
-----------------------------------------------------------------------------------------------------------------------------------
IONTOPHORESIS
-----------------------------------------------------------------------------------------------------------------------------------
IO-01 7247.25 2930.25 Epidermal Iontophorolic Device SCJ, RLS, et al. 8/16/76
-----------------------------------------------------------------------------------------------------------------------------------
IO-02 7247.26 2930.02 Fluid Self-Sealing Bioelectrode SCJ, RLS, RDL, et al. 11/14/77
-----------------------------------------------------------------------------------------------------------------------------------
IO-03 7247.27 2930.06 Non-Invasive Chemical Species SCJ, JCS, RLS, RDL 11/22/78
Delivery Apparatus and Method
-----------------------------------------------------------------------------------------------------------------------------------
IO-03-EP 7247.27a 2930.06EP Non-Invasive Chemical Species RLS, RDL 11/20/79
Delivery Apparatus and Method
-----------------------------------------------------------------------------------------------------------------------------------
IO-03-JP 7247.27b 2930.06JP Non-Invasive Chemical Species RLS, RDL 11/9/79
Delivery Apparatus and Method
-----------------------------------------------------------------------------------------------------------------------------------
IO-04 7247.28 2930.20 Ion Mobility Limiting Iontophoretic SCJ, RDL 2/23/81
Bioelectrode
-----------------------------------------------------------------------------------------------------------------------------------
IO-04-CN 7247.28a 2930.20CN Ion Mobility Limiting Iontophoretic SCJ, RDL 2/19/82
Bioelectrode
-----------------------------------------------------------------------------------------------------------------------------------
IO-04-EP 7247.28b 2930.20EP Ion Mobility Limiting Iontophoretic SCJ, RDL 2/16/82
Bioelectrode
-----------------------------------------------------------------------------------------------------------------------------------
IO-04-JP 7247.28c 2930.20JP Ion Mobility Limiting Iontophoretic SCJ, RDL 10/21/81
Bioelectrode
-----------------------------------------------------------------------------------------------------------------------------------
IO-05-IFG 7247.29 2930.03 Infringement of #4,416,274 SCJ 5/10/91
-----------------------------------------------------------------------------------------------------------------------------------
IO-06 7247.30 2930.09 Iontophoretic Electrode Structure SCJ, RDL, BKH 11/6/61
-----------------------------------------------------------------------------------------------------------------------------------
IO-07 7247.30.1 2930.09.1 Iontophoretic Electrode Structure SCJ, RDL, BKH 9/27/83
-----------------------------------------------------------------------------------------------------------------------------------
IO-08 7247.8 2930.14 Methods & Apparatus for Iontophoresis TJP, RLS, SCJ, JJ 3/19/86
(silver) Application of Medicaments
-----------------------------------------------------------------------------------------------------------------------------------
IO-08-EP 7247.8a 2930.14EP Methods & Apparatus for Iontophoresis TJP, RLS, SCJ, JJ 3/11/87
Application of Medicaments
-----------------------------------------------------------------------------------------------------------------------------------
IO-08-JP 7247.8b 2930.14JP Methods & Apparatus for Iontophoresis TJP, RLS, SCJ, JJ 3/19/87
Application of Medicaments
-----------------------------------------------------------------------------------------------------------------------------------
IO-09 7247.8.1 2930.14C Methods & Apparatus for Iontophoresis TJP, RLS, SCJ, JJ 4/5/89
Vol. I & II Application of Medicaments
-----------------------------------------------------------------------------------------------------------------------------------
IO-10 7247.15 2930.16 Flow-Through Methods & Apparatus SCJ, TJP, RLS 6/19/87
for Iontophoresis Application of
Medicaments at a Controlled pH
-----------------------------------------------------------------------------------------------------------------------------------
5/14/93
-----------------------------------------------------------------------------------------------------------------------------------
IOMED # APPL. NO. STATUS. ISSUED NUMBER ASSIGNED TO ACTION
-----------------------------------------------------------------------------------------------------------------------------------
IONTOPHORESIS
-----------------------------------------------------------------------------------------------------------------------------------
IO-01 714,942 issued 2/27/79 4,141,359 Univ. of Utah NAR
-----------------------------------------------------------------------------------------------------------------------------------
IO-02 851,082 issued 9/4/79 4,166,457 Univ. of Utah NAR
-----------------------------------------------------------------------------------------------------------------------------------
IO-03 963,029 issued 2/17/81 4,250,878 Motion Control Name change
filed
-----------------------------------------------------------------------------------------------------------------------------------
IO-03-EP 79104616.2 issued 8/4/82 0011813 Motion Control MF due 11/93
-----------------------------------------------------------------------------------------------------------------------------------
IO-03-JP 150793/79 issued 3/12/84 1,195,921 Motion Control A. due 5/13/93
-----------------------------------------------------------------------------------------------------------------------------------
IO-04 236,753 issued 11/22/83 4,416,274 Motion Control NAR
-----------------------------------------------------------------------------------------------------------------------------------
IO-04-CN 396,679 issued 1/22/85 1181490 Motion Control NAR
-----------------------------------------------------------------------------------------------------------------------------------
IO-04-EP 82101141.8 issued 9/1/82 0058920 Motion Control A. pd. 2/93
-----------------------------------------------------------------------------------------------------------------------------------
IO-04-JP 26921/82 issued 8/15/91 1,614,476 Motion Control NAR
-----------------------------------------------------------------------------------------------------------------------------------
IO-05-IFG NAR
-----------------------------------------------------------------------------------------------------------------------------------
IO-06 319,074 issued 12/6/83 4,419,092 Motion Control NAR
-----------------------------------------------------------------------------------------------------------------------------------
IO-07 536,304 issued 10/23/84 4,477,971 Motion Control NAR
-----------------------------------------------------------------------------------------------------------------------------------
IO-08 841,329 issued 6/21/88 4,752,285 UU Res. Found. Inquiry with
(silver) ▇. ▇▇▇▇▇▇
-----------------------------------------------------------------------------------------------------------------------------------
IO-08-EP 87302061.4 pending UU Res. Found. Resp. O/A filed
A. pd.
-----------------------------------------------------------------------------------------------------------------------------------
IO-08-JP 65522/87 pending UU Res. Found. Exam decision
1/93
-----------------------------------------------------------------------------------------------------------------------------------
IO-09 90/001,744 Re-exam 4,752,285 UU Res. Found. 9/30 complaint
Vol. I & II filed
-----------------------------------------------------------------------------------------------------------------------------------
IO-10 7/064,813 issued 12/12/89 4,886,489 Univ. of Utah MF due 6/93
-----------------------------------------------------------------------------------------------------------------------------------
13
EXHIBIT "B"
To License Agreement between
University of Utah Research Foundation
and Iomed, Inc.
[Pg 2 of 3]
IOMED PATENTS, TRADEMARKS AND APPLICATIONS
-----------------------------------------------------------------------------------------------------------------------------------
IOMED # WNJ NO. HHD NO. TITLE INVENTORS FILED
-----------------------------------------------------------------------------------------------------------------------------------
IO-10-EP 7247.15a 2930.16EP Flow-Through Methods & Apparatus SCJ, TJP, RLS 2/6/88
for Ionlophoresis Application of
Medicaments at a Contolled pH
-----------------------------------------------------------------------------------------------------------------------------------
IO-10-JP 7247.15b 2930.16JP Flow-Through Methods & Apparatus SCJ, TJP, RLS 6/20/88
for Iontophoresis Application of
Medicaments at a Controlled pH
-----------------------------------------------------------------------------------------------------------------------------------
IO.11 7247.10 2930.15 Methods & Apparatus for Iontophoresis TJP, SCJ, RLS, JJ 6/19/87
Vol. I-85/88 Application of Medicaments at a
Vol. II 89- Contolled pH Through Ion Exchange
-----------------------------------------------------------------------------------------------------------------------------------
IO-11-EP 7247.10a 2930.15EP Methods & Apparatus for Iontophoresis TJP, SCJ, RLS, JJ 6/8/88
Application of Medicaments at a
Controlled pH Through Ion Exchange
-----------------------------------------------------------------------------------------------------------------------------------
IO-11-JP 7247.10b 2930.15JP Methods & Apparatus for Iontophoresis TJP, SCJ, RLS, JJ 6/20/86
Application of Medicaments at a
Controlled pH Through Ion Exchange
-----------------------------------------------------------------------------------------------------------------------------------
IO-12 7237.31 2930.04 Iontophoretic Electrode With Solution SCJ, TJP, ▇▇▇, RLS 5/8/89
Containment System
-----------------------------------------------------------------------------------------------------------------------------------
IO-12-EP 7247.31a 2930.04EP Iontophoretic Electrode With Solution SCJ, TJP, ▇▇▇, RLS 11/14/90
Containment System
-----------------------------------------------------------------------------------------------------------------------------------
12-JP 7247.31b 2930.04JP Iontophoretic Electrode With Solution SCJ, TJP, ▇▇▇, RLS 5/9/90
Containment System
-----------------------------------------------------------------------------------------------------------------------------------
IO-13 7247.31.1 2930.04.1 Iontophoretic Electrode With Solution SCJ, TJP, ▇▇▇, RLS 8/23/90
Containment System
-----------------------------------------------------------------------------------------------------------------------------------
IO-14 7247.32 2930.1 Bioelectrode Seal SCJ, TJP, ▇▇▇, RLS 5/8/89
-----------------------------------------------------------------------------------------------------------------------------------
IO-14.1 7247.32.1 2930.10.1 Bioelectrode Seal SCJ, TJP, ▇▇▇, RLS 5/21/91
-----------------------------------------------------------------------------------------------------------------------------------
IO-14.2 2930.10.2 Bioelectrode Containing Silicon Gel Seal SCJ, TJP, ▇▇▇, RLS
-----------------------------------------------------------------------------------------------------------------------------------
IO-15 7247.33 2930.01 Method of Iontophoretically Treating RLS, TJP, SCJ 5/11/89
Acne, Furuncies & Like Skin Disorders
-----------------------------------------------------------------------------------------------------------------------------------
IO-15-EP 7247.33a 2930.01EP Method of Iontophoretically Treating RLS, TJP, SCJ 10/5/90
Acne, Furuncies & Like Skin Disorders
-----------------------------------------------------------------------------------------------------------------------------------
IO-15-JP 7247.33b 2930.01JP Method of Iontophoretically Treating RLS, TJP, SCJ 5/11/90
Acne, Furuncies & Like Skin Disorders
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
IOMED # APPL. NO. STATUS ISSUED NUMBER ASSIGNED TO ACTION
-----------------------------------------------------------------------------------------------------------------------------------
IO-01-EP 8830566.6 pending Univ. of Utah U of U action
due 6/20/93
-----------------------------------------------------------------------------------------------------------------------------------
IO-10-JP 152068/88 pending Univ. of Utah NAR
-----------------------------------------------------------------------------------------------------------------------------------
IO-11 7/064,769 issued 4/10/90 4,915,685 Univ. of Utah MF due 10/93
Vol. I-85/86 EMPIREX
Vol. II 89
-----------------------------------------------------------------------------------------------------------------------------------
IO-12-EP 88305243.3 pending Iomed, Inc. A due 6/8/93
-----------------------------------------------------------------------------------------------------------------------------------
IO-11-JP 152068/88 pending Iomed, Inc. Review
R for E due
1995
-----------------------------------------------------------------------------------------------------------------------------------
IO-12 7/349,489 issued 11/5/90 4,968,297 Iomed, Inc. MF due 2/6/94
-----------------------------------------------------------------------------------------------------------------------------------
IO-12-EP 90/108643.9 pending Iomed, Inc. MR due 5/93
-----------------------------------------------------------------------------------------------------------------------------------
12-JP 117787/90 pending Iomed, Inc. NAR
-----------------------------------------------------------------------------------------------------------------------------------
IO-13 7/572,477 issued 8/6/91 5,037,380 Iomed, Inc. NAR
-----------------------------------------------------------------------------------------------------------------------------------
IO-14 7/348/596 abandoned Iomed, Inc. NAR
-----------------------------------------------------------------------------------------------------------------------------------
IO-14.1 7/703,456 allowed Iomed, Inc. issue fee pd.
-----------------------------------------------------------------------------------------------------------------------------------
IO-14.2 in prep. Ready to file?
-----------------------------------------------------------------------------------------------------------------------------------
IO-15 7/350.227 issued 12/25/90 4,979,938 Iomed, Inc. NAR
-----------------------------------------------------------------------------------------------------------------------------------
IO-15-EP 90108838.5 pending Iomed, Inc. A. due 5/93
-----------------------------------------------------------------------------------------------------------------------------------
IO-15-JP 122780/90 pending Iomed, Inc. NAR
-----------------------------------------------------------------------------------------------------------------------------------
2
14
EXHIBIT "B"
To License Agreement between
University of Utah Research Foundation
and Iomed, Inc.
[Pg 3 of 3]
IOMED PATENTS, TRADEMARKS AND APPLICATIONS
-----------------------------------------------------------------------------------------------------------------------------------
IOMED # WNJ NO. HHD NO. TITLE INVENTORS FILED
-----------------------------------------------------------------------------------------------------------------------------------
IONTOPHORESIS
-----------------------------------------------------------------------------------------------------------------------------------
IO-06 7247.34 2930.05 Hydratable Bioelectrode TJP, SCJ, RLS, JB, LL 7/21/89
-----------------------------------------------------------------------------------------------------------------------------------
IO-16-CN 7247.34a 2930.05CN Hydratable Bioelectrode TJP, SCJ, RLS, JB, LL 9/29/89
-----------------------------------------------------------------------------------------------------------------------------------
IO-16-EP 7247.34b 2930.05EP Hydratable Bioelectrode TJP, SCJ, RLS, JB, LL 7/11/90
-----------------------------------------------------------------------------------------------------------------------------------
IO-16-JP 7247.34c 2930.05JP Hydratable Bioelectrode TJP, SCJ, RLS, JB, LL 7/18/90
-----------------------------------------------------------------------------------------------------------------------------------
IO-17 7247.34.1 2930.05.1 Hydratable Bioelectrode TJP, SCJ, RLS, JB, LL 1/23/91
-----------------------------------------------------------------------------------------------------------------------------------
IO-16 7247.34.2 2930.01.1 Rehydratable Product & Method of LBL, ▇▇▇, TJP, SCJ 12/14/90
(TransO) Preparation Thereof
-----------------------------------------------------------------------------------------------------------------------------------
IO-19 7247.33.1 2930.37 Method of Treating Infection of a TJP, NMW, SCJ 11/2/90
Fingernail, Toenail and the Like
-----------------------------------------------------------------------------------------------------------------------------------
IO-20 7247.33.2 2930.38 Apparatus For Treating & Preventing ▇▇▇, LBL, TJP, NW, 11/2/90
Infection of a Fingernail, Toenail & the Like SCJ
-----------------------------------------------------------------------------------------------------------------------------------
IO-21 7247.34.2.1 2930.33 An iontophoretic Bioelectrode LBL, ▇▇▇, TJP, SCJ 6/2/92
Incorporating Hydratable Element and
Method of Preparation Thereof
-----------------------------------------------------------------------------------------------------------------------------------
IO-21-PCT 7247.34.2.1a 2930.33PCT An iontophoretic Bioelectrode LBL, ▇▇▇, TJP, SCJ 12/16/91
Incorporating Hydratable Element and
Method of Preparation Thereof
-----------------------------------------------------------------------------------------------------------------------------------
MOTION CONTROL
-----------------------------------------------------------------------------------------------------------------------------------
MC-01 2930.19 Constant Tension Traction Device SCJ, DFK, RDL 7/22/82
-----------------------------------------------------------------------------------------------------------------------------------
MC-02 2930.3 Electrically Driven Artificial Arm SCJ, DFK, RTJ 3/1/83
-----------------------------------------------------------------------------------------------------------------------------------
MC-03 7247.40 2930.31 Articulated Prosthetic Wrist SCJ 10/5/84
-----------------------------------------------------------------------------------------------------------------------------------
5/14/93
-----------------------------------------------------------------------------------------------------------------------------------
IOMED # APPL. NO. STATUS ISSUED NUMBER ASSIGNED TO ACTION
-----------------------------------------------------------------------------------------------------------------------------------
IONTOPHORESIS
-----------------------------------------------------------------------------------------------------------------------------------
IO-16 7/383,939 issued 2/11/92 5,087,242 Iomed, Inc. NAR
-----------------------------------------------------------------------------------------------------------------------------------
IO-16-CN 614,496 pending Iomed, Inc. Rsp. to CN PTO
-----------------------------------------------------------------------------------------------------------------------------------
IO-16-EP 90113284.5 pending Iomed, Inc. NAR
-----------------------------------------------------------------------------------------------------------------------------------
IO-16-JP 188182/90 pending Iomed, Inc. NAR
-----------------------------------------------------------------------------------------------------------------------------------
IO-17 7/645,028 pending Iomed, Inc. Refile case
-----------------------------------------------------------------------------------------------------------------------------------
IO-18 7/627,714 allowed Iomed, Inc. Issue fee pd.
-----------------------------------------------------------------------------------------------------------------------------------
IO-19 7/609,181 pending Iomed, Inc. Resp. to O/A
filed
-----------------------------------------------------------------------------------------------------------------------------------
IO-20 7/608,565 pending Iomed, Inc. Resp. to O/A
filed 10/20/92
-----------------------------------------------------------------------------------------------------------------------------------
IO-21 7/892,341 pending Iomed, Inc. NAR
-----------------------------------------------------------------------------------------------------------------------------------
IO-21-PCT PCT/US91 pending Iomed, Inc. NAR
/09329
-----------------------------------------------------------------------------------------------------------------------------------
MOTION CONTROL
-----------------------------------------------------------------------------------------------------------------------------------
MC-01 400,914 issued 11/20/84 4,483,330 Motion Control MF not pd. uu?
-----------------------------------------------------------------------------------------------------------------------------------
MC-02 470,927 issued 6/11/85 4,521,924 Univ. of Utah MF due pd.
-----------------------------------------------------------------------------------------------------------------------------------
MC-03 658,192 issued 9/23/86 4,613,331 Univ. of Utah 2nd A. 3/94
-----------------------------------------------------------------------------------------------------------------------------------
3
15
EXHIBIT "C"
To License Agreement between
University of Utah Research Foundation
and Iomed, Inc.
[Pg 1 of 1]
IOMED PATENTS, TRADEMARKS AND APPLICATIONS
-----------------------------------------------------------------------------------------------------------------------------------
IOMED # WNJ NO. HHD NO. TITLE INVENTORS FILED
-----------------------------------------------------------------------------------------------------------------------------------
DRUG DELIVERY
-----------------------------------------------------------------------------------------------------------------------------------
DD-01 2930.4 Implantable Catheter System AF 2/14/77
-----------------------------------------------------------------------------------------------------------------------------------
DD-02 2930.41 Peritoneal Dialysis Catheter WJK, TRK 8/26/77
-----------------------------------------------------------------------------------------------------------------------------------
DD-03 5339.10 2930.42 Subcutaneous Peritoneal Injection RLS 10/27/80
Catheter
-----------------------------------------------------------------------------------------------------------------------------------
DD-04 5339.10a 2930.43 Subcutaneous Peritoneal Injection RLS, CK, BKH, SCJ, 2/17/81
Catheter JJH
-----------------------------------------------------------------------------------------------------------------------------------
DD-05 5339.23 2930.44 Apparatus & Methods for Minimizing DEG, RLS, DLC, SKH, 8/12/83
Cellular Adhesion on Peritoneal BKH, JJH
Injection Catheters
-----------------------------------------------------------------------------------------------------------------------------------
DD-05-CN 5339.22b 2930.44CN Apparatus and Methods for Minimizing DEG, RLS, DLC, SKH, 11/13/84
Cellular Adhesion on Peritoneal BKH, JJH
Injection Catheters
-----------------------------------------------------------------------------------------------------------------------------------
DD-06 5339.20 2930.46 Apparatus & Method of Minimizing RLS, CK, BKH, SCJ 8/12/83
Peritoneal Injection Catheter Obstruc.
-----------------------------------------------------------------------------------------------------------------------------------
DD-07-EP 5339.22 2930.45EP Peritoneal Injection Catheter RLS, BKH, CK, SCJ, 8/22/83
Apparatus & Method JJH, DLC, DEG, SKH
-----------------------------------------------------------------------------------------------------------------------------------
DD-07-CN 5339.22a 2930.45CN Peritoneal Injection Catheter RLS, CK, BKH, SCJ, 11/13/84
Apparatus & Method JJH
-----------------------------------------------------------------------------------------------------------------------------------
5/14/93
-----------------------------------------------------------------------------------------------------------------------------------
IOMED # APPL. NO. STATUS. ISSUED NUMBER ASSIGNED TO ACTION
-----------------------------------------------------------------------------------------------------------------------------------
DRUG DELIVERY
-----------------------------------------------------------------------------------------------------------------------------------
DD-01 768,520 issued 7/10/79 4,160,454 Univ. of Utah Don't pay MF
-----------------------------------------------------------------------------------------------------------------------------------
DD-02 828,019 issued 1/22/80 4,184,497 Univ. of Utah as above
-----------------------------------------------------------------------------------------------------------------------------------
DD-03 200,830 issued 8/23/83 4,400,169 UU Res. Found. as above
-----------------------------------------------------------------------------------------------------------------------------------
DD-04 235,185 issued 9/20/83 4,405,305 UU Res. Found. 3rd A. due
3/20/95
-----------------------------------------------------------------------------------------------------------------------------------
DD-05 522,914 issued 12/10/85 4,557,724 UU Res. Found. 2nd A due
6/10/93
-----------------------------------------------------------------------------------------------------------------------------------
DD-05-CN 467,690 issued 3/15/88 1234030 UU Res. Found. NAR
-----------------------------------------------------------------------------------------------------------------------------------
DD-06 522,907 issued 12/17/85 4,559,033 UU Res. Found. 2nd A due
6/7/93
-----------------------------------------------------------------------------------------------------------------------------------
DD-07-EP 83304828.3 issued 3/20/85 134,340 UU Res. Found. Don't pay MF
-----------------------------------------------------------------------------------------------------------------------------------
DD-07-CN 467,671 issued 3/15/88 1,234,029 UU Res. Found. NAR
-----------------------------------------------------------------------------------------------------------------------------------
16
[UNIVERSITY OF UTAH LOGO]
EXHIBIT "D"
To License Agreement between
University of Research Foundation and Iomed, Inc.
[Pg. 1 of 11]
June 9, 1993
▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇
IOMED, Incorporated
1290 West ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇ ▇
▇▇▇▇ ▇▇▇▇ ▇▇▇▇, ▇▇▇▇ ▇▇▇▇▇
RE: IOMED License Agreement (U-671D)
Dear ▇▇▇:
In accordance with paragraph 11.1 of the revised agreement which we are
currently negotiating, the University and I want to disclose to IOMED that we
are aware of a Sarcos project on a mechanical artificial arm that Dr. Jaocobsen
is involved in.
It is our understanding that the Department of Veterans Affairs is funding
the project at Sarcos, and although some machining work may be done at the
University, no inventive work will be involved at the University.
Since this is a mechanical device and a Sarcos project without University
rights involved, paragraph 11.2 should not apply.
If you have any questions, please don't hesitate to call.
Yours truly,
/s/ ▇▇▇ MAJOR
--------------------------
▇▇▇ Major
Director
TM/pls
cc: ▇▇▇▇▇ ▇▇▇▇▇▇▇▇
Technology Transfer ▇▇▇▇▇▇
▇▇▇ ▇▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇ ▇▇▇
▇▇▇▇ ▇▇▇▇ ▇▇▇▇, ▇▇▇▇ ▇▇▇▇▇
(▇▇▇) ▇▇▇-▇▇▇▇
FAX: (▇▇▇) ▇▇▇-▇▇▇▇